When it comes to
medical cannabis,
OWC believes in
science instead of
mythology aiming
to produce pharmaceutical-grade cannabis-based products
and treatments that
are:
• Standardized in
composition, formulation and dose;
• Administered by
means of the appropriate and efficient
innovative delivery
systems
• Tested in properly
controlled pre-clinical and clinical
studies.
CANNAINVESTOR Magazine
Research
One World Cannabis: Research Division for Cannabis
Headquartered in Israel, the birthplace of modern medical cannabis research, the Research Division leverages the Company’s extensive network comprising some of Israel’s leading researchers, scientists, universities and hospitals, as well as cannabis breeders and extractors, to
study and test the effectiveness of different combinations of cannabinoids in the treatment of disease and chronic conditions.
One World Cannabis is focused on discovering, developing and commercializing cannabis-based novel therapeutics products and treatments specifically designed for several medical conditions, starting
with multiple myeloma, psoriasis, fibromyalgia, migraine and PTSD
(post-traumatic stress disorder).
To date, One World Cannabis completed two of three new innovative
delivery systems of active cannabinoids, with its own formulas. The new
delivery systems will be safe to use with controlled dosage and long
lasting quality. The delivery systems will be clinically tested through
OWC’s studies.
To date, One World Cannabis has signed three research collaboration
agreements with the biggest academic hospital in Israel, which is also
the largest hospital in the Middle East. Within the framework of these
agreements, the company will initiate pre-clinical and clinical studies
to explore the effect of several combinations of cannabidiol (CBD) and
tetrahydrocannabinol (THC) on multiple myeloma (a cancer of plasma
cells), psoriasis and fibromyalgia.
One World Cannabis will continue to collaborate with other industry
partners, as well as leading academic medical centers, in order to develop, clinically research, produce, and commercialized novel cannabinoid-based therapies targeting a variety of different indications and
effectively help patients in need.
Upon the successful completion of clinical trials and the development